Page 54 - Orphan News Today

STOCKHOLM, Oct. 27, 2022 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its report for the third quarter of 2022 July - September 2022 Total revenue SEK

NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1FDA Expands the Scope of the Company's SubmissionAccelerates Path Toward Immunotherapy for Glioblastoma (Brain Cancer)CLEVELAND

Afghan-American activists have expressed indignation after reports suggested that a US Marine and his wife abducted a baby girl during the chaotic American military withdrawal from Afghanistan in August last year.

Antagonist anti-CD89 will be developed for the treatment of Linear IgA Bullous Dermatosis. JJP Biologics, a company that specializes in the development of proprietary biologic agents for personalized

Josh Anderson, with Respire Haiti, joined News15 at Noon to share about Respire Haiti. Anderson details how the non-profit was started and share how they need the communities help to

Michael McKnight is at it again.

Completion of preclinical studies support potential to advance PXL770 into Phase 2 development for ADPKD Compelling preclinical efficacy data confirm strategic focus for PXL770 in rare metabolic

Thinking of applying for NSFAS funding but not sure if you can? Here's a plug.

In 2019, when he was 25 years old he learned that he had the Shingles virus. At that moment, he knew something needed to change.

In 2019, when he was 25 years old he learned that he had the Shingles virus. At that moment, he knew something needed to change.